[登录] [免费注册]
试剂仪器网
发布求购
位置：首页 > 资料中心 > 化工字典 > 70024-40-7
关键词:       仅模糊查询
CAS: 70024-40-7
分子式: C19H26ClN5O4
分子量: 423.89
沸点: 271-274°C
中文名称: 
盐酸特拉唑嗪
特拉唑嗪盐酸盐
1-(4-氨基-6,7-二甲基-2-喹唑啉基)-4-(四氢呋喃-2-甲酰)哌嗪盐酸盐
四喃唑嗪
盐酸特拉唑嗪二水合物
英文名称: 
terazosin monohydrochloride dihydrate
Hytrinex
arbonyl )-, monohydrochloride, dihydrate
iperazine hcl 2h2o
terazosin hydrochloride dihydrate
terazosin hcl
性质描述: 外观：类白或白色结晶性粉末有关物质：≤1.0%干燥失重：≤9.0%炽灼残渣：≤0.1%重金属：≤10ppm含量：≥99.0%生产厂家(当前命中:7条/共7条)[关闭窗口] 简库 全库 北京第二制药厂 简库 全库 天津市华新制药厂简库 全库 常州新华化学制品有限公司简库 全库 常州新华实业总公司简库 全库 金坛市爱德医药原料化工厂简库 全库 金坛市松盛医药化工研究所实验厂简库 全库 海南绿岛制药有限公司
推荐供应商
货号品牌产品名称规格包装、参考价格详情
A793616MACKLIN1-(4-氨基-6, 7-二甲氧基-2-喹唑啉基)-4-[(四氢呋喃-2-甲酰基)哌嗪盐酸盐二水合物10mM in DMSO362元/1ml;   展开
储存：-20°C
A858032MACKLIN1-(4-氨基-6,7-二甲氧基-2-喹唑啉基)-4-[(四氢呋喃-2-甲酰基)哌嗪盐酸盐二水合物98%40元/1g;   128元/5g;   504元/25g;   1736元/100g;   展开
储存： 2-8°C
状态：白色到几乎白色粉末或晶体
T2751TCITerazosin Hydrochloride Dihydrate>98.0%(HPLC)(N)190元/100MG;   990元/1G;   展开

基本信息

纯度/分析方法>98.0%(HPLC)(N)
分子式/分子量C19H25N5O4・HCl・2H2O = 459.93
外观与形状(20℃)固体
相关CAS RN63590-64-7&63074-08-8
Reaxys-RN6495493
PubChem物质ID125307764
MDL编号MFCD00941408

技术规格

AppearanceWhite to Almost white powder to crystal
Purity(HPLC)min. 98.0 area%
Purity(with Total Nitrogen)min. 98.0 %
Water7.0 to 9.0 %

物性(参考值)

熔点274 ℃

相关法规

RTECS#TK8046000
PHR1721SupelcoTerazosin hydrochloridePharmaceutical Secondary Standard; Certified Reference Material1003.39元/1 G;   展开

产品说明

一般描述

Terazosin Hydrochloride belongs to the class of a1-adrenergic blockers, widely used for the treatment of benign prostatic hyperplasia (BPH) affecting the urogenital tract in men.
Certified pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Certified pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards

应用

Terazosin Hydrochloride may be used as a drug standard stock solution for the determination of terazosin hydrochloride dihydrate using potentiometric and fluorimetric techniques.
Terazosin Hydrochloride may be used as a pharmaceutical reference standard for the quantification of the analyte in pharmaceutical formulations using high-performance thin layer chromatography.
These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
It may be used as drug standard stock solution for determination of terazosin hydrochloride dihydrate using potentiometric and fluorimetric techniques.

分析说明

These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.

其他说明

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

附注

To see an example of a Certificate of Analysis for this material enter LRAA7395 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.

基本信息

经验(实验)分子式C19H25N5O4 · HCl · 2H2O
分子量459.92
MDL编号MFCD00941408
PubChem化学物质编号329823574
NACRESNA.24

产品性质

质量水平300
等级certified reference material
pharmaceutical secondary standard
CofAcurrent certificate can be downloaded
包装pkg of 1 g
technique(s)HPLC: suitable
gas chromatography (GC): suitable
application(s)pharmaceutical (small molecule)
格式neat
储存温度2-30℃
SMILES stringO.O.Cl.COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4
InChI1S/C19H25N5O4.ClH.2H2O/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14;;;/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22);1H;2*1H2
InChI keyNZMOFYDMGFQZLS-UHFFFAOYSA-N
Gene Informationhuman ... ADRA1A(148), ADRA1B(147), ADRA1D(146)

安全信息

象形图GHS07
警示用语：Warning
危险声明H319
预防措施声明P264 - P280 - P305 + P351 + P338 - P337 + P313
危险分类Eye Irrit. 2
储存分类代码11 - Combustible Solids
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
Y0000621Terazosin Hydrochloride DihydrateEuropean Pharmacopoeia (EP) Reference Standard1277.32元/ ;   展开

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

包装

Unit quantity: 40 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

注意

Please find SDS provided by EDQM here..

其他说明

Sales restrictions may apply.

基本信息

经验(实验)分子式C19H25N5O4 · HCl · 2H2O
分子量459.92
MDL编号MFCD00941408
PubChem化学物质编号329831056
NACRESNA.24

产品性质

等级pharmaceutical primary standard
manufacturer/tradenameEDQM
application(s)pharmaceutical (small molecule)
格式neat
SMILES stringO.O.Cl.COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4
InChI1S/C19H25N5O4.ClH.2H2O/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14;;;/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22);1H;2*1H2
InChI keyNZMOFYDMGFQZLS-UHFFFAOYSA-N
Gene Informationhuman ... ADRA1A(148), ADRA1B(147), ADRA1D(146)

安全信息

象形图GHS07
警示用语：Warning
危险声明H319
预防措施声明P264 - P280 - P305 + P351 + P338 - P337 + P313
危险分类Eye Irrit. 2
储存分类代码11 - Combustible Solids
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
Y0000666Terazosin for system suitabilityCRS, European Pharmacopoeia (EP) Reference Standard1556.7元/0.59 mg;   展开

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
Terazosin hydrochloride is a quinazoline derivative. It is a alpha-1-selective adrenoceptor blocking agent. It has been used to treat hypertension, as it helps the blood vessels to relax, expand and improves blood flow.

应用

It may be used as drug standard stock solution for determination of terazosin hydrochloride dihydrate using potentiometric and fluorimetric techniques.

包装

Unit quantity: 0.59 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

注意

Please find SDS provided by EDQM here..

其他说明

Sales restrictions may apply.

基本信息

经验(实验)分子式C19H25N5O4 · HCl · 2H2O
分子量459.92
MDL编号MFCD00941408
PubChem化学物质编号329831082
NACRESNA.24

产品性质

等级pharmaceutical primary standard
manufacturer/tradenameEDQM
application(s)pharmaceutical (small molecule)
格式neat
SMILES stringO.O.Cl.COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4
InChI1S/C19H25N5O4.ClH.2H2O/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14;;;/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22);1H;2*1H2
InChI keyNZMOFYDMGFQZLS-UHFFFAOYSA-N
Gene Informationhuman ... ADRA1A(148), ADRA1B(147), ADRA1D(146)

安全信息

象形图GHS07
警示用语：Warning
危险声明H302
危险分类Acute Tox. 4 Oral
储存分类代码13 - Non Combustible Solids
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
Y0002268Beta-sitosterol for peak identificationEuropean Pharmacopoeia (EP) Reference Standard1341.2元/ ;   展开

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

包装

Unit quantity: 10 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

其他说明

Sales restrictions may apply.

基本信息

经验(实验)分子式C19H25N5O4 · HCl · 2H2O
分子量459.92
MDL编号MFCD00941408

产品性质

manufacturer/tradenameEDQM
储存温度−20℃
SMILES stringO.O.Cl.COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4
InChI1S/C19H25N5O4.ClH.2H2O/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14;;;/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22);1H;2*1H2
InChI keyNZMOFYDMGFQZLS-UHFFFAOYSA-N

安全信息

储存分类代码11 - Combustible Solids
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
1643452USPTerazosin hydrochlorideUnited States Pharmacopeia (USP) Reference Standard3231.47元/200 MG;   展开

产品说明

一般描述

Terazosin hydrochloride is a quinazoline derivative. It is a alpha-1-selective adrenoceptor blocking agent. It has been used to treat hypertension, as it helps the blood vessels to relax, expand and improves blood flow.

应用

It may be used as drug standard stock solution for determination of terazosin hydrochloride dihydrate using potentiometric and fluorimetric techniques.

分析说明

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

其他说明

USP issued SDS can be found here.
Sales restrictions may apply.

基本信息

经验(实验)分子式C19H25N5O4 · HCl · 2H2O
分子量459.92
MDL编号MFCD00941408
PubChem化学物质编号329751228
NACRESNA.24

产品性质

等级pharmaceutical primary standard
manufacturer/tradenameUSP
application(s)pharmaceutical (small molecule)
格式neat
SMILES stringO.O.Cl.COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4
InChI1S/C19H25N5O4.ClH.2H2O/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14;;;/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22);1H;2*1H2
InChI keyNZMOFYDMGFQZLS-UHFFFAOYSA-N
Gene Informationhuman ... ADRA1A(148), ADRA1B(147), ADRA1D(146)

安全信息

象形图GHS07
警示用语：Warning
危险声明H319
预防措施声明P264 - P280 - P305 + P351 + P338 - P337 + P313
危险分类Eye Irrit. 2
储存分类代码11 - Combustible Solids
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
Y0002286Terazosin for system suitability AEuropean Pharmacopoeia (EP) Reference Standard1341.2元/ ;   展开

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

包装

Unit quantity: 0.59 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

其他说明

Sales restrictions may apply.

基本信息

经验(实验)分子式C19H25N5O4 · HCl · 2H2O
分子量459.92
MDL编号MFCD00941408

产品性质

manufacturer/tradenameEDQM
储存温度2-8℃
SMILES stringO.O.Cl.COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4
InChI1S/C19H25N5O4.ClH.2H2O/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14;;;/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22);1H;2*1H2
InChI keyNZMOFYDMGFQZLS-UHFFFAOYSA-N

安全信息

象形图GHS07
警示用语：Warning
危险声明H319
预防措施声明P264 - P280 - P305 + P351 + P338 - P337 + P313
危险分类Eye Irrit. 2
储存分类代码11 - Combustible Solids
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
358112Fluorochem6,7-dimethoxy-2-[4-(oxolane-2-carbonyl)piperazin-1-yl]quinazolin-4-amine hydrochloride>98.0%(HPLC)(N)264元/1g;   726元/5g;   1144元/10g;   展开

基本信息

CAS Number70024-40-7
MDL NumberMFCD00467965
CAS号首数字顺序排列： 1 2 3 4 5 6 7 8 9